• ALS News

  Target ALS and AFTD Announce Partnership to Spur Development of ALS Biomarkers

  Posted by Dagmar on October 15, 2019 at 12:24 pm

  

  The Association for Frontotemporal Degeneration (AFTD) and Target ALS announced a groundbreaking partnership and call for proposals to identify treatments and biomarkers for FTD and ALS. These two devastating, progressive diseases are now understood to overlap in genetic causes and biological mechanisms.

  At the center of our partnership is a $5 million multi-year grant-making initiative that will spur collaboration and form research consortia comprised of scientists from academia and the pharmaceutical/biotech industry. These consortia will work to discover, validate, and develop specific candidate drug targets or candidate biomarkers that may translate into new therapeutic strategies or validated biomarkers for ALS and FTD.

  What do you think of this news? Is Frontotemporal Degeneration one of your concerns living with or caring for someone with ALS?

  Dagmar replied 4 years, 7 months ago 1 Member · 0 Replies

  • AFDT
  • ALS research
  • ALS treatment
  • Frontotemporal Degeneration
  • research
  • Target ALS
• 0 Replies

Log In to Reply